NOBIVAC CANINE DAPPVL2
Canine Distemper Virus, Canine Adenovirus 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), and Leptospira Canicola-Icterohaemorrhagiae
Recommended for use in healthy dogs 6 weeks of age or older.
Protects against all known strains of canine parvovirus (CPV), including CPV-2c
First to publish data showing protection against CPV-2c challenge
Contains CPV-2b, one of the most prevalent field strains of parvovirus
High antigenic mass (titer), low passage parvovirus vaccine
Overrides maternal antibodies in young puppies
Frequently Bought Together
Customers who bought this item also bought
NOBIVAC CANINE DAPPVL2
- Protects against all known strains of canine parvovirus (CPV), including CPV-2c
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- Overrides maternal antibodies in young puppies
- Defends against 2 strains of Leptospira: L. canicola and L. icterohaemorrhagiae
- Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
- Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus, in 1 formula
Additional information
| Weight | 0.5 kg |
|---|
Indications
Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper, adenovirus types 1 and 2, parainfluenza, parvovirus, and leptospiral disease due to L. canicola or L. icterohaemorrhagiae.Recommended for use in healthy dogs 6 weeks of age or older.
Administration and Dosage
- Subcutaneous or intramuscular injection
- Two 1 mL doses given 2 to 4 weeks apart
- Repeat at 2 to 4 week intervals until the dog is 12 weeks of age
- Annual revaccination with 1 dose is recommended
- Available in a 25 x 1 mL dose presentation
Reviews
There are no reviews yet.